|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 7.960 USD | -1.00% |
|
-0.31% | -4.50% |
| 08-13 | Rockwell Medical, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | Rockwell Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 32.08M 27.64M 26.17M 23.72M 44.51M 3.07B 44.73M 311M 120M 1.56B 120M 118M 4.93B | P/E 2026 * |
-7.88x | P/E 2027 * | -10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 32.08M 27.64M 26.17M 23.72M 44.51M 3.07B 44.73M 311M 120M 1.56B 120M 118M 4.93B | EV / Sales 2026 * |
0.44x | EV / Sales 2027 * | 0.41x |
| Free-Float |
85.2% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RMTI | Delayed | |
Tradegate
| RWM | Real-time | |
|
CBOE
| RMTI | Real-time | |
|
Börse Stuttgart
| RWM | Delayed | |
|
Deutsche Boerse AG
| RWM | Delayed |
Last Transcript : Rockwell Medical, Inc.
| 1 day | -1.00% | ||
| 1 week | -0.31% | ||
| Current month | -4.21% | ||
| 1 month | +12.43% | ||
| 3 months | +27.85% | ||
| 6 months | -11.94% | ||
| Current year | -4.50% |
| 1 week | 7.28 |  | 8.34 |
| 1 month | 7.04 | | 8.5 |
| Current year | 4.88 | | 12.9 |
| 1 year | 4.88 | | 17.2 |
| 3 years | 4.88 | | 51.5 |
| 5 years | 4.88 | | 73.37 |
| 10 years | 4.88 | | 987.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Strobeck
CEO | Chief Executive Officer | 73 | 2022-06-30 |
Jesse Neri
DFI | Director of Finance/CFO | 48 | 2024-12-11 |
Heather Hunter
COO | Chief Operating Officer | 47 | 2025-09-22 |
| Director | Title | Age | Since |
|---|---|---|---|
John Cooper
BRD | Director/Board Member | 67 | 2017-09-06 |
Mark Ravich
BRD | Director/Board Member | 73 | 2017-05-31 |
Robert Radie
CHM | Chairman | 73 | 2022-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/1/26 | Free | Director | 9,633 | 0.0244% | ||
| 7/1/26 | Free | Chief Financial Officer | 15,000 | 0.0380% | ||
| 7/1/26 | Free | Executive/Senior Manager | 15,000 | 0.0380% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.00% | -0.31% | -52.90% | -64.30% | 32.6M | |
| -0.65% | -2.93% | +47.52% | +87.34% | 994B | |
| -0.29% | -3.51% | +48.78% | +63.27% | 640B | |
| +0.83% | +0.26% | +16.76% | +72.52% | 454B | |
| -0.38% | -3.59% | +28.24% | +35.57% | 337B | |
| -0.09% | -13.54% | +10.08% | +26.87% | 261B | |
| -0.43% | -2.48% | -2.07% | +11.48% | 246B | |
| -1.34% | -13.70% | +33.47% | +44.18% | 204B | |
| -3.44% | -7.51% | -20.08% | -59.58% | 190B | |
| -0.75% | -4.82% | +21.94% | +86.55% | 178B | |
| Average | -0.76% | -5.21% | +13.17% | +30.39% | 350.48B | |
| Weighted average by Cap. | -0.51% | -4.42% | +29.86% | +55.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 72.34M 62.33M 59.02M 53.49M 100M 6.91B 101M 701M 270M 3.52B 272M 266M 11.11B | 78.15M 67.34M 63.76M 57.79M 108M 7.47B 109M 757M 291M 3.8B 294M 287M 12B |
| Net income | -3.94M -3.39M -3.21M -2.91M -5.46M -376M -5.49M -38.15M -14.67M -191M -14.79M -14.46M -605M | -3.34M -2.87M -2.72M -2.47M -4.63M -319M -4.65M -32.32M -12.43M -162M -12.53M -12.25M -512M |
| Net Debt | - | - |
Employees
157
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | US$7.960 | -1.00% | 42,754 |
| 26-09-10 | US$8.040 | +1.07% | 36,509 |
| 26-09-09 | US$7.955 | -1.30% | 21,388 |
| 26-09-08 | US$8.060 | +0.94% | 33,184 |
| 26-09-04 | US$7.985 | 0.00% | 6,582 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.960USD
Average target price
20.00USD
Spread / Average Target
+151.26%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMTI Stock
Select your edition
All financial news and data tailored to specific country editions
